Best Telehealth Clinics in Ohio (2026)

Ohio permanently expanded telehealth through HB 122 (the Telemedicine Expansion Act), signed by Governor DeWine on December 22, 2021, effective March 23, 2022. The law is codified at Ohio Revised Code (ORC) 4743.09. It established payment parity, expanded eligible provider types, and made Medicaid coverage of telehealth services permanent. Final telehealth rules from the State Medical Board of Ohio became effective February 28, 2023.

Ohio does require an in-person examination of new patients before prescribing controlled substances via telehealth under Ohio Administrative Code Rule 4731-11-09. Exceptions exist for hospice and palliative care patients and medication-assisted treatment for opioid use disorder. The federal DEA extension through December 31, 2026 currently overrides this state requirement for Schedule II through V substances, including testosterone (Schedule III).

Ohio is an active member of the Interstate Medical Licensure Compact. Physicians from other IMLC states can obtain an Ohio license through the expedited pathway. Ohio also participates in the OARRS (Ohio Automated Rx Reporting System), the state's prescription drug monitoring program. Prescribers must check OARRS before issuing controlled substance prescriptions.

The Ohio Board of Pharmacy is more active than most state pharmacy boards on compounding regulation. In July 2025, the Board issued formal GLP-1 compounding guidance and a FAQ document. The key rules: compounded semaglutide and tirzepatide can no longer be justified on drug shortage grounds; compounding is only permitted for individualized, medically necessary formulations with documented patient-specific clinical justification; active pharmaceutical ingredients must come from an Ohio-licensed drug distributor. The Board is actively enforcing these restrictions.

Ohio's telehealth framework is one of the more comprehensive permanent codifications in the country, but the in-person requirement for controlled substances and the active pharmacy board enforcement on compounding are two areas that set Ohio apart.

Ohio has 11.8 million residents and is the seventh-largest state. Provider availability is strong, with IMLC membership and a permanent telehealth framework making the state attractive to providers. Of the 64 providers tracked, roughly 55 serve Ohio.

All major TRT providers serve Ohio. Maximus ($100/mo with labs, all 50 states), Hone Health ($25/mo entry, all 50 states), TRT Nation ($99/mo, serves 45 states including OH), BraverX ($129/mo with labs), PeterMD ($99/mo annual), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available. Defy Medical ($200/mo) and Marek Health ($166/mo) serve "Most US states" and include Ohio.

GLP-1 availability is technically unrestricted at the state level, though the Ohio Board of Pharmacy's active enforcement on compounding means patients may find fewer compounded semaglutide options than in less regulated states. All 50-state providers (Embody, SkinnyRx, DirectMeds, Remedy Meds, GobyMeds, Sesame Care, Shed, MEDVi, Sunlight, Mochi Health) serve Ohio. Providers that use non-Ohio-licensed compounding pharmacies may face compliance issues.

All HRT providers are available. Midi Health accepts insurance. All hair loss and ED providers serve the state. Enhance MD does not appear to exclude Ohio. Peptide providers including Maximus and Defy Medical are available.

Feel30 excludes several states for TRT but does not appear to exclude Ohio specifically. Their enclomiphene service is available in all 50 states.

TRT costs in Ohio track national averages. DudeMeds: $77/mo (labs $200 extra, $1,124/year). TRT Nation: $99/mo (labs $258 extra, $1,446/year). PeterMD: $99/mo annual (labs included, $1,188/year, upfront payment). Maximus: $100/mo annual (labs included, $1,300/year). Titan Medical: $99/mo (labs $229 extra, $1,417/year). BraverX: $129/mo (labs included, $1,548/year). Henry Meds: $129/mo (labs included, $1,548/year). Defy Medical: $200/mo ($2,800/year).

GLP-1 pricing ranges from $99/mo (Embody, SkinnyRx, Zealthy) to $399/mo (TrimRx). GobyMeds at $119/mo for compounded semaglutide, though patients should verify the compounding pharmacy is Ohio-licensed given the Board's enforcement. Fridays at $117/mo includes coaching. The median across providers is $179/mo.

Ohio Medicaid does not cover GLP-1s for adult weight loss. Coverage is limited to type 2 diabetes. Ohio spent $431 million on GLP-1s in FY2024, almost entirely for diabetes indications. Ohio state employee GLP-1 coverage for weight loss was terminated July 1, 2025, then replaced with a partial reimbursement weight management program effective October 7, 2025. This is separate from Medicaid.

Ohio does not tax prescription medications. The state sales tax rate is 5.75% but does not apply to Rx drugs or telehealth consultations.

HRT ranges from $0 (Midi Health with insurance) to $149/mo (Hone Premium). ED: Hims $17/mo to MEDVi $119/mo. Hair loss: Hims $20/mo to Nutrafol $88/mo.

TRT (testosterone replacement therapy)

Ohio Administrative Code Rule 4731-11-09 requires an in-person exam for new patients before controlled substance telehealth prescribing. The federal DEA waiver through 2026 overrides this. Testosterone (Schedule III) is currently prescribable via telehealth. Both compounded and FDA-approved testosterone are available. OARRS must be checked. Once the DEA waiver expires, Ohio patients will need an in-person visit before starting TRT online.

GLP-1 weight loss

No state ban on GLP-1 telehealth prescribing. However, the Ohio Board of Pharmacy's July 2025 guidance tightened compounding rules: compounded semaglutide requires documented patient-specific clinical justification and APIs from Ohio-licensed distributors. Federal FDA rules also apply. Brand-name Wegovy and Zepbound are unaffected by compounding restrictions.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Ohio. No additional state restrictions apply. All HRT providers serve the state.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Ohio. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Ohio. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Ohio. The Board of Pharmacy's stricter compounding enforcement may affect some peptide formulations. Sermorelin, BPC-157, and NAD+ are available from Maximus and Defy Medical. Patients should verify compounding pharmacy compliance with Ohio requirements.